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The adult liver represents a paradigm of bona fide regeneration whereby after damage it can fully 
restore its architecture and function. Following mild and moderate injury, this regeneration occurs via 
hepatocyte proliferation [1]. However, in severe chronic liver disease, the regenerative capacity of 
hepatocytes becomes impaired  [2][3], leading to failure of the hepatocyte compartment to fully 
restore normal structure and function. The question of whether cells of a non-hepatocyte origin, such 
as biliary cells, can contribute to parenchymal repair in such a setting cannot yet be determined from 
human tissue samples. Animal models of liver disease have therefore been used which allow cell fate 
tracing to try and answer this question. However, these studies have produced conflicting and 
contradictory results. 
Hepatocyte self-duplication has been considered to be the sole mechanism of parenchymal 
regeneration. Yanger et al. [4] and Schaub et al. [5] showed independently, through labelling of 
multiple cells types within the liver, that regeneration after injury is mediated via hepatocyte 
proliferation rather than from extra-hepatic sources. Font-Burgada et al. [6] further identified a 
population of regeneratively-proficient hepatocytes within the periportal region These cells express a 
combination of hepatocyte and biliary genes and respond to injury with extensive proliferation and can 
repopulate the liver following injury [6].  
Hepatic progenitor cells (HPCs) have also been proposed as source of hepatocyte regeneration, 
however there has been controversy regarding their nature. HPCs have been described as cells of 
biliary origin that reside in the canals of Hering in a quiescent state and during severe injury they 
proliferate and expand into the parenchyma in atypical structures, termed ductular reactions (DRs) [7]. 
Biliary derived cells contribute to parenchymal restoration, although minimally, following chronic CCL4 
treatment and partial hepatectomy [8]. However, these aforementioned injury models fail to reproduce 
a key characteristic feature of chronic liver disease in humans – that of significant hepatocyte 
senescence. Other rodent models, described below, have attempted to induce widespread 
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hepatocyte senescence or inhibit hepatocyte proliferation to recapitulate the replicative arrest 
observed in hepatocytes in human disease.   
Transplanted mouse HPCs  engraft and expand as hepatocytes in a mouse model in which deletion 
of the negative regulator of p53 – Mdm2 – leads to widespread hepatocyte senescence and 
parenchymal injury, thus creating a non-competitive repopulation environment [9]. Two recent studies 
investigated the relationship between a defect in native hepatocyte replication and the contribution of 
biliary-derived hepatocytes to parenchymal regeneration. Raven and Lu [10] explored multiple models 
combining inhibition of hepatocyte proliferation, either via Itgb1 deletion or p21 overexpression, and 
diet-induced liver injury models (DDC, MCD, TAA) to show that biliary-derived hepatocytes can 
contribute to restore a proportion of the liver parenchyma, but only when the native hepatocytes are 
unable to proliferate. Russel et al. [11]  explored a model where native hepatocyte regeneration is 
impaired via β-catenin deletion and observed  robust HPC-to-hepatocyte differentiation during the 
recovery phase from CDE-induced liver injury. Another study by Deng et al. [12] used long-term injury 
models (up to 52 weeks TAA and up to 24 weeks DDC), where there was a time-dependent induction 
of native hepatocyte senescence, combined with lineage tracing, to show that biliary-derived 
hepatocytes could regenerate liver parenchyma.  
The present study [13] adds to the evidence for the role of biliary-derived hepatocytes in restoration of 
the liver parenchyma following chronic liver injury. The authors rely on mice with an inducible 
Osteopontin-iCreER
T2 
allele to label biliary cells with several different marker genes- YFP, mT/mG or 
confetti. They used this technique to trace biliary cells and their derivatives to define their role in liver 
regeneration following chronic liver injury induced by repeated CCl4 injection. It should be noted that 
there is some evidence in the injured liver, that OPN expression is not strictly restricted to the biliary 
compartment but is also present in other cell types, including damaged hepatocytes [14]. This could 
affect whether the genetic label is strictly related to biliary cells or could be non-specifically expressed 
in hepatocytes. The authors therefore performed stringent control experiments to minimise the 
possibility that the emergence of biliary-derived hepatocytes in their model is an artefact of the 
labelling system. The authors use a three times-a-week CCl4 injection regime for up to 24 weeks that 
the authors describe as “severe”. This results in discrete and transient DR formation, progressive 
central fibrosis and gradual failure of regeneration by the hepatocyte compartment. In agreement with 
Raven and Lu [10] and Russel [11],  the authors emphasise the requirement for inhibition of native 
hepatocyte proliferation to observe a significant, biliary-mediated regenerative response. Furthermore, 
emergence of biliary-derived hepatocytes in this model coincided with decreased proliferative activity 
in native hepatocytes. The authors provide data suggesting that the drop in proliferative index in 
native hepatocytes is due to the acquisition of a senescent phenotype. Senescent cells are known to 
secrete a cocktail of soluble proteins, termed senescence-associated secretory phenotype (SASP), 
through which they can influence the fate of surrounding tissue in a paracrine manner [15]. It is 
therefore tempting to hypothesise that SASP factors, secreted by senescent native hepatocytes 
influence the differentiation of biliary cells towards a hepatocyte phenotype. However, one cannot 
exclude other factors being relevant, for example proliferative hepatocytes may themselves inhibit 
biliary differentiation. Further studies are therefore required to determine the signals controlling the 
biliary-to-hepatocyte fate change. 
In patients with chronic liver disease, the development of fibrosis is correlated with widespread 
hepatocyte senescence and persistent DR [16] [3]. The chronic CCl4 injury regime described here 
recapitulates the first two features; the authors report a mild and transient DR response at onset of 
injury that disappears by the time significant numbers of biliary-derived hepatocytes are seen. 
Therefore, the authors hypothesise that the biliary-derived hepatocyte patches observed in this model 
are a result of clonal expansion of rare differentiation events and not multiple biliary cells 
differentiating simultaneously. Interestingly, the experiments performed using the OPN-Cre; 
Rosa26R
Confetti 
mouse suggest this holds true as no mosaicism was observed within the biliary-derived 
hepatocyte patches- in other words the biliary derived hepatocyte patches were clonal. However, 
caution must be exercised when translating such findings to other models of liver disease, where 
injury is accompanied by florid DR and the activation of the biliary compartment diminishes only after 
the hepatotoxic agent is removed. 
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The authors investigate whether the damage response elicited by CCl4 administration differs between 
native and biliary-derived hepatocytes. Although both native populations exhibit similar levels of DNA 
damage during injury, the biliary-derived hepatocytes are shown to have less activation of pathways 
associated with apoptosis and cellular senescence, as well as lower levels of nuclear polyploidy, 
which is linked to cellular stress. During the injury recovery phase, the biliary-derived hepatocytes 
have a proliferative advantage over the native hepatocytes, and are able to resolve previously 
accumulated DNA damage, as indicated by elimination of nuclear γ-H2A foci. Therefore, the increase 
in number of biliary-derived hepatocytes during recovery is, again, attributed to clonal expansion and 
not de novo differentiation. Of note, the native hepatocytes are exposed to CCl4 for substantially 
longer than biliary-derived hepatocytes (which appear from week 6 of CCl4 treatment onwards), thus 
the longer exposure to the hepatotoxic agent can cause the native hepatocytes to be more damaged, 
and more likely to enter apoptosis or senescence. 
The proliferative advantage of the biliary-derived hepatocytes could be considered a double-edged 
sword. Whereas this might be beneficial for regeneration, uncontrolled proliferation can also lead to 
development of cancer. Importantly, to investigate whether the biliary-derived hepatocytes possess a 
malignant predisposition, the authors subjected mice to 24-week CCl4 treatment to model the pre-
neoplastic nodules of cirrhosis. Although a fraction of the cirrhotic nodules were composed of YFP
+ 
biliary-derived hepatocytes or were mosaics between YFP
+
/YFP
-
 cells, the majority of nodules were 
composed of YFP
-
 native hepatocytes. Exposure to the hepatocarcinogen DEN led to the 
development of hepatocellular carcinoma (HCC) nodules that were composed of native, YFP
- 
hepatocytes. This is in agreement with a recent study from Tummala el al. [17], where HCCs are 
shown to originate from damaged hepatocytes.  
The present study contributes significant extra information to the knowledge of biliary-mediated 
hepatocyte regeneration. Considering that the only definitive treatment option for patients with end-
stage chronic liver disease is transplantation and demand for donor organs far outweighs availability, 
describing the endogenous regenerative mechanism including biliary-mediated regeneration is 
important. It may be that if we can understand the molecular pathways governing the replication 
failure of hepatocytes and biliary-to-hepatocyte differentiation we can target these for clinical benefit. 
However for this to be realised clinically, a rigorous understanding of the pathways concerned is 
required to guarantee safety of such approaches. 
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Figure legends 
Fig. 1. Rodent models of chronic liver disease, in which the biliary-derived hepatocytes 
contribute to parenchymal regeneration 
In chronic injury, when the native hepatocytes are able to proliferate normally, the biliary-derived 
hepatocytes contribute minimally to parenchymal restoration even in injury scenarios with widespread 
hepatocyte loss (1.). In chronic injury, when the capacity of the native hepatocytes to proliferate is 
impaired, the biliary-derived hepatocytes contribute significantly to parenchymal regeneration (2.). In 
prolonged chronic injury and compromised native hepatocyte proliferation, the biliary-derived 
hepatocytes contribute to parenchymal restoration. Importantly, the damaged, native hepatocytes are 
susceptible to malignant transformation (3.).  
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